TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T06955	C-C chemokine receptor type 4	D0Y3DN	Flavonoid derivative 4	Patented	5280343	C15H10O7	302.23	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O	IC50 = 100000 nM	Poor binder
T06955	C-C chemokine receptor type 4	B1BT2C	2-((1R,4R)-2-Furan-3-yl-5-{[(naphthalen-1-ylmethyl)-carbamoyl]-methyl}-4-oxo-thiazolidin-3-yl)-N-(3-morpholin-4-yl-propyl)-acetamide	Investigative	44288557	C29H34N4O5S	550.7	C1COCCN1CCCNC(=O)CN2[C@H](S[C@@H](C2=O)CC(=O)NCC3=CC=CC4=CC=CC=C43)C5=COC=C5	IC50 = 100000 nM	Poor binder
T06955	C-C chemokine receptor type 4	B25OTD	2-((1R,4R)-2-(2,4-Bis-trifluoromethyl-phenyl)-5-{[(naphthalen-1-ylmethyl)-carbamoyl]-methyl}-4-oxo-thiazolidin-3-yl)-N-(3-morpholin-4-yl-propyl)-acetamide	Investigative	44288733	C33H34F6N4O4S	696.7	C1COCCN1CCCNC(=O)CN2[C@H](S[C@@H](C2=O)CC(=O)NCC3=CC=CC4=CC=CC=C43)C5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F	IC50 ~ 100000 nM	Poor binder
T06955	C-C chemokine receptor type 4	B6W4XZ	N-(3-Morpholin-4-yl-propyl)-2-((1R,4R)-5-{[(naphthalen-1-ylmethyl)-carbamoyl]-methyl}-4-oxo-2-thiophen-3-yl-thiazolidin-3-yl)-acetamide	Investigative	44289057	C29H34N4O4S2	566.7	C1COCCN1CCCNC(=O)CN2[C@H](S[C@@H](C2=O)CC(=O)NCC3=CC=CC4=CC=CC=C43)C5=CSC=C5	IC50 = 66000 nM	Poor binder
T06955	C-C chemokine receptor type 4	B7YCA2	2-((1R,4R)-2-Cyclohexyl-5-{[(naphthalen-1-ylmethyl)-carbamoyl]-methyl}-4-oxo-thiazolidin-3-yl)-N-(3-morpholin-4-yl-propyl)-acetamide	Investigative	44288863	C31H42N4O4S	566.8	C1CCC(CC1)[C@@H]2N(C(=O)[C@H](S2)CC(=O)NCC3=CC=CC4=CC=CC=C43)CC(=O)NCCCN5CCOCC5	IC50 = 100000 nM	Poor binder
T06955	C-C chemokine receptor type 4	BJ4Z5D	2-((1R,4R)-2-Benzyl-5-{[(naphthalen-1-ylmethyl)-carbamoyl]-methyl}-4-oxo-thiazolidin-3-yl)-N-(3-morpholin-4-yl-propyl)-acetamide	Investigative	44288725	C32H38N4O4S	574.7	C1COCCN1CCCNC(=O)CN2[C@H](S[C@@H](C2=O)CC(=O)NCC3=CC=CC4=CC=CC=C43)CC5=CC=CC=C5	IC50 ~ 100000 nM	Poor binder
T06955	C-C chemokine receptor type 4	BK8V2F	11-Butyl-3-[1-(4,6-dimethylpyrimidine-5-carbonyl)-4-methyl-4-piperidyl]-9-[(4-ethoxycyclohexyl)methyl]-3,9-diazaspiro[5.5]undecan-10-one	Investigative	25230828	C35H57N5O3	595.9	CCCCC1C(=O)N(CCC12CCN(CC2)C3(CCN(CC3)C(=O)C4=C(N=CN=C4C)C)C)CC5CCC(CC5)OCC	IC50 ~ 50000 nM	Poor binder
T06955	C-C chemokine receptor type 4	BM13SH	2-[(2R,5R)-2-(2,4-Dichloro-phenyl)-3-(3-morpholin-4-ylmethyl-benzyl)-4-oxo-thiazolidin-5-yl]-N-naphthalen-1-ylmethyl-acetamide	Investigative	44289207	C34H33Cl2N3O3S	634.6	C1COCCN1CC2=CC(=CC=C2)CN3[C@H](S[C@@H](C3=O)CC(=O)NCC4=CC=CC5=CC=CC=C54)C6=C(C=C(C=C6)Cl)Cl	IC50 = 100000 nM	Poor binder
T06955	C-C chemokine receptor type 4	BN4YF8	PharmaGSID_48521	Investigative	44555481	C31H49N5O4	555.8	CCCC[C@H]1CN(C(=O)OC12CCN(CC2)C3(CCN(CC3)C(=O)C4=C(N=CN=C4C)C)C)CC5CCOCC5	IC50 ~ 50000 nM	Poor binder
T06955	C-C chemokine receptor type 4	BP0GC3	3-(4-(4-Fluorophenyl)piperazin-1-yl)-5,7-dihydroxy-4-methyl-2H-chromen-2-one	Investigative	45104747	C20H19FN2O4	370.4	CC1=C(C(=O)OC2=CC(=CC(=C12)O)O)N3CCN(CC3)C4=CC=C(C=C4)F	IC50 = 58500 nM	Poor binder
T06955	C-C chemokine receptor type 4	BUKE12	N-(3-Morpholin-4-yl-propyl)-2-((1R,4R)-5-{[(naphthalen-1-ylmethyl)-carbamoyl]-methyl}-4-oxo-2-phenethyl-thiazolidin-3-yl)-acetamide	Investigative	44288899	C33H40N4O4S	588.8	C1COCCN1CCCNC(=O)CN2[C@H](S[C@@H](C2=O)CC(=O)NCC3=CC=CC4=CC=CC=C43)CCC5=CC=CC=C5	IC50 = 100000 nM	Poor binder